MARKET

IXHL

IXHL

Incannex Healthcare Ltd
NASDAQ
0.3580
-0.0021
-0.58%
After Hours: 0.3580 0 0.00% 19:59 12/31 EST
OPEN
0.3578
PREV CLOSE
0.3601
HIGH
0.3635
LOW
0.3466
VOLUME
8.37M
TURNOVER
--
52 WEEK HIGH
2.250
52 WEEK LOW
0.0800
MARKET CAP
123.95M
P/E (TTM)
-0.3819
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IXHL last week (1222-1226)?
Weekly Report · 12/29/2025 10:20
This Cannabis Stock Got Destroyed in 2025. Can Trump Make 2026 a Different Story?
Barchart · 12/25/2025 08:00
Weekly Report: what happened at IXHL last week (1215-1219)?
Weekly Report · 12/22/2025 10:20
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 12/18/2025 21:05
Incannex Healthcare Adjourns 2025 Annual Stockholder Meeting
TipRanks · 12/18/2025 11:30
Weekly Report: what happened at IXHL last week (1208-1212)?
Weekly Report · 12/15/2025 10:27
Weekly Report: what happened at IXHL last week (1201-1205)?
Weekly Report · 12/08/2025 10:26
BUZZ-U.S. STOCKS ON THE MOVE-Microsoft, Wyndham Hotels & Resorts, Daktronics
Reuters · 12/03/2025 15:57
More
About IXHL
Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing combination medicines that target the underlying biological pathways associated with chronic conditions, including obstructive sleep apnoea, rheumatoid arthritis, and generalized anxiety disorder. Its lead clinical program, IHL-42X, is an oral fixed-dose combination of dronabinol and acetazolamide designed to target underlying mechanisms and act synergistically in the treatment of obstructive sleep apnoea. IHL-42X has completed a Phase II clinical trial. PSX-001 is a synthetic psilocybin treatment for the treatment of generalized anxiety disorder. PSX-001 has completed a Phase II clinical trial. IHL-675A is an oral fixed-dose combination of cannabidiol and hydroxychloroquine sulfate designed to act synergistically to alleviate inflammatory conditions, such as rheumatoid arthritis. IHL-675A is in a Phase II clinical development program.

Webull offers Incannex Healthcare Inc stock information, including NASDAQ: IXHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IXHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IXHL stock methods without spending real money on the virtual paper trading platform.